Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
EMA Safety Commission Recommends Withdrawal Of Esmya Authorizations
Follows March Suspension By EMA
Sep 07 2020
•
By
Dean Rudge
The PRAC recommendation will now be forwarded to EMA’s CHMP • Source: Shutterstock
More from Regulation
More from Policy & Regulation